Britain criticized for vaccination delay

October 13, 2007

Critics say delaying a cervical cancer vaccination program could condemn 1,400 more British girls to develop the disease and 420 to die from it.

Government health advisers are expected to recommend next week that all 12-year-old girls be routinely vaccinated against the virus, The Telegraph reported Saturday.

But the program is not due to start until September 2008, leaving at risk the 1,400 girls who could benefit from the vaccination this year, the British newspaper reported.

The issue is controversial because the virus primarily is spread through sexual contact and some worry the vaccine will encourage underage sex.

British health ministers have been accused of backsliding on the issue of mass vaccination, which already is conducted in France, Germany, the United States and Australia.

Copyright 2007 by United Press International

Explore further: HPV may lurk in your throat

Related Stories

HPV may lurk in your throat

January 31, 2018
Human papilloma virus (HPV), the culprit behind cervical cancer and some forms of head and neck cancer may hide in small pockets on the surface of tonsils in people not known to carry the virus. The finding, reported by University ...

Papua's deadly measles outbreak shows decades of neglect: experts

January 28, 2018
Indonesia's battle to stem a deadly measles outbreak striking malnourished children in Papua is doomed to be repeated unless the government helps lift the isolated region out of grinding poverty, observers said.

HPV vaccine is effective, safe 10 years after it's given

November 29, 2017
A decade of data on hundreds of boys and girls who received the HPV vaccine indicates the vaccine is safe and effective long term in protecting against the most virulent strains of the virus, researchers report.

NIH and partners launch HIV vaccine efficacy study

November 30, 2017
The National Institutes of Health and partners have launched a large clinical trial to assess whether an experimental HIV vaccine regimen is safe and able to prevent HIV infection. The new Phase 2b proof-of-concept study, ...

Opportunities to vaccinate young women against HPV missed at alarming rate

December 18, 2017
Two-thirds of young women aged 18-26 who were eligible to receive Human Papilloma Virus (HPV) vaccine have missed at least one opportunity to receive the vaccine during a visit to an obstetrics and gynecology clinic, Yale ...

Young girls more likely to report side effects after HPV vaccine

April 3, 2012
Younger girls are more likely than adult women to report side effects after receiving Gardasil, the human papillomavirus vaccine. The side effects are non-serious and similar to those associated with other vaccines, according ...

Recommended for you

Researchers use a molecular Trojan horse to deliver chemotherapeutic drug to cancer cells

February 23, 2018
A research team at the University of California, Riverside has discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases.

Lab-grown 'mini tumours' could personalise cancer treatment

February 23, 2018
Testing cancer drugs on miniature replicas of a patient's tumour could help doctors tailor treatment, according to new research.

An under-the-radar immune cell shows potential in fight against cancer

February 23, 2018
One of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreading in the body, according to new research from the University of British Columbia.

Study tracks evolutionary transition to destructive cancer

February 23, 2018
Evolution describes how all living forms cope with challenges in their environment, as they struggle to persevere against formidable odds. Mutation and selective pressure—cornerstones of Darwin's theory—are the means ...

Putting black skin cancer to sleep—for good

February 22, 2018
An international research team has succeeded in stopping the growth of malignant melanoma by reactivating a protective mechanism that prevents tumor cells from dividing. The team used chemical agents to block the enzymes ...

Cancer risk associated with key epigenetic changes occurring through normal aging process

February 22, 2018
Some scientists have hypothesized that tumor-promoting changes in cells during cancer development—particularly an epigenetic change involving DNA methylation—arise from rogue cells escaping a natural cell deterioration ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.